Phibro Animal Health Corporation (PAHC)
Phibro (PAHC) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for Phibro (PAHC) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Phibro Animal Health (PAHC) Tops Q1 Earnings Estimates
Phibro Animal Health (PAHC) came out with quarterly earnings of $0.35 per share, beating the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.14 per share a year ago.
Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
PAHC Stock Likely to Gain From Its Latest Acquisition of Zoetis
Phibro successfully acquires Zoetis Inc.'s MFA portfolio and certain water-soluble products.
Phibro Animal Health (PAHC) Earnings Expected to Grow: Should You Buy?
Phibro (PAHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Finding Great Top-Ranked Momentum Stocks to Buy Now
The stocks we learn to search for today are top-ranked momentum stocks that might be worth buying to close out October and throughout the last two months of 2024.
PAHC vs. PODD: Which Stock Is the Better Value Option?
Investors interested in Medical - Products stocks are likely familiar with Phibro Animal Health (PAHC) and Insulet (PODD). But which of these two stocks is more attractive to value investors?
Is Phibro Animal Health (PAHC) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
New Animal Health Products, Vaccine Sales Support PAHC Stock
Phibro Animal Health is focusing on new developments, incremental registrations and volumes of existing vaccine technologies.
PAHC or ABT: Which Is the Better Value Stock Right Now?
Investors interested in Medical - Products stocks are likely familiar with Phibro Animal Health (PAHC) and Abbott (ABT). But which of these two companies is the best option for those looking for undervalued stocks?
Phibro (PAHC) Up 2.9% Since Last Earnings Report: Can It Continue?
Phibro (PAHC) reported earnings 30 days ago. What's next for the stock?
